BIORESTORATIVE THERAPIES, INC. Basic Shares Outstanding (Weighted Average)
BIORESTORATIVE THERAPIES, INC. (BRTX) reported Basic Shares Outstanding (Weighted Average) of 17.73 million shares for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-14.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-05-14
- BIORESTORATIVE THERAPIES, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 17.73M shares, a 112.13% increase year-over-year.
- BIORESTORATIVE THERAPIES, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 9.75M shares, a 19.95% increase year-over-year.
- BIORESTORATIVE THERAPIES, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 9.12M shares, a 12.25% increase year-over-year.
- BIORESTORATIVE THERAPIES, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-06-30 was 8.74M shares, a 7.62% increase year-over-year.
- BIORESTORATIVE THERAPIES, INC. weighted average number of shares outstanding, basic for fiscal 2025 was 8.99M shares, a 15.83% increase from fiscal 2024.
- BIORESTORATIVE THERAPIES, INC. weighted average number of shares outstanding, basic for fiscal 2024 was 7.76M shares, a 84.05% increase from fiscal 2023.
- BIORESTORATIVE THERAPIES, INC. weighted average number of shares outstanding, basic for fiscal 2023 was 4.22M shares, a 16.60% increase from fiscal 2022.
- BIORESTORATIVE THERAPIES, INC. weighted average number of shares outstanding, basic for fiscal 2022 was 3.62M shares, a 204.60% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|
| 2026-03-31 | 17.73M shares 10-Q · filed 2026-05-14 | 13.74M shares derived: average of 2 quarters · filed 2026-05-14 | 12.20M shares derived: average of 3 quarters · filed 2026-05-14 | 11.33M shares derived: average of 4 quarters · filed 2026-05-14 |
| 2025-12-31 | 9.75M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | 9.43M shares derived: average of 2 quarters · filed 2026-03-26 | 9.20M shares derived: average of 3 quarters · filed 2026-03-26 | 8.99M shares 10-K · filed 2026-03-26 |
| 2025-09-30 | 9.12M shares 10-Q · filed 2025-11-12 | 8.93M shares derived: average of 2 quarters · filed 2025-11-12 | 8.74M shares 10-Q · filed 2025-11-12 | 8.58M shares derived: average of 4 quarters · filed 2026-05-14 |
| 2025-06-30 | 8.74M shares 10-Q · filed 2025-08-12 | 8.55M shares 10-Q · filed 2025-08-12 | 8.41M shares derived: average of 3 quarters · filed 2026-05-14 | 8.34M shares derived: average of 4 quarters · filed 2026-05-14 |
| 2025-03-31 | 8.36M shares 10-Q · filed 2026-05-14 | 8.24M shares derived: average of 2 quarters · filed 2026-05-14 | 8.20M shares derived: average of 3 quarters · filed 2026-05-14 | 8.18M shares derived: average of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | 8.13M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | 8.12M shares derived: average of 2 quarters · filed 2026-03-26 | 8.12M shares derived: average of 3 quarters · filed 2026-03-26 | 7.76M shares 10-K · filed 2026-03-26 |
| 2024-09-30 | 8.12M shares 10-Q · filed 2025-11-12 | 8.12M shares derived: average of 2 quarters · filed 2025-11-12 | 7.64M shares 10-Q · filed 2025-11-12 | 6.90M shares derived: average of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | 8.12M shares 10-Q · filed 2025-08-12 | 7.40M shares 10-Q · filed 2025-08-12 | 6.49M shares derived: average of 3 quarters · filed 2025-08-12 | 6.01M shares derived: average of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | 6.67M shares 10-Q · filed 2025-05-14 | 5.68M shares derived: average of 2 quarters · filed 2025-05-14 | 5.31M shares derived: average of 3 quarters · filed 2025-05-14 | 4.95M shares derived: average of 4 quarters · filed 2025-05-14 |
| 2023-12-31 | 4.69M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | 4.63M shares derived: average of 2 quarters · filed 2025-03-28 | 4.38M shares derived: average of 3 quarters · filed 2025-03-28 | 4.22M shares 10-K · filed 2025-03-28 |
| 2023-09-30 | 4.57M shares 10-Q · filed 2024-11-12 | 4.23M shares derived: average of 2 quarters · filed 2024-11-12 | 4.06M shares 10-Q · filed 2024-11-12 | 3.96M shares derived: average of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | 3.89M shares 10-Q · filed 2024-08-13 | 3.80M shares 10-Q · filed 2024-08-13 | 3.76M shares derived: average of 3 quarters · filed 2024-08-13 | 3.73M shares derived: average of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | 3.72M shares 10-Q · filed 2024-06-11 | 3.69M shares derived: average of 2 quarters · filed 2024-06-11 | 3.67M shares derived: average of 3 quarters · filed 2024-06-11 | 3.67M shares derived: average of 4 quarters · filed 2024-06-11 |
| 2022-12-31 | 3.66M shares derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-06-11 | 3.65M shares derived: average of 2 quarters · filed 2024-06-11 | 3.65M shares derived: average of 3 quarters · filed 2024-06-11 | 3.62M shares 10-K/A · filed 2024-06-11 |
| 2022-09-30 | 3.64M shares 10-Q · filed 2023-11-13 | 3.64M shares derived: average of 2 quarters · filed 2023-11-13 | 3.60M shares 10-Q · filed 2023-11-13 | |
| 2022-06-30 | 3.64M shares 10-Q · filed 2023-08-11 | 3.58M shares 10-Q · filed 2023-08-11 | ||
| 2022-03-31 | 3.52M shares 10-Q · filed 2023-05-12 | |||
| 2021-12-31 | 1.19M shares 10-K · filed 2023-03-27 | |||
| 2020-06-30 | 1.59B shares 10-Q · filed 2021-04-12 | 1.28B shares 10-Q · filed 2021-04-12 | ||
| 2019-06-30 | 17.51M shares 10-Q · filed 2021-04-12 | 15.60M shares 10-Q · filed 2021-04-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |